Interim Medical & Scientific Affairs Lead (Final Signatory) Location: UK/Remote Start: June/July 2025 Focus: Rare Disease | Ophthalmology An exciting opportunity for an experienced ABPI Final Signatory to lead the Medical & Scientific Affairs function for the UK launch of a first-in-class orphan-designated therapy in ophthalmology. This is a strategic interim role supporting early access, governance, and scientific engagement ahead of a landmark UK launch in 2026. Key Points: Interim contract — 2–3 days per week (flexible) ABPI Final Signatory certification (essential) Strong Medical Affairs leadership experience Rare disease or orphan drug exposure is a plus Compassionate Use or Named Patient Programme experience (nice to have) Ophthalmology background (nice to have) Fully remote with occasional travel Thsi is a start up situation, so you will be shaping the medical governance framework, driving scientific strategy, and partnering cross-functionally to ensure a successful pre-launch phase within a lean, agile setup. Contract: Approximately 6–9 months, through to post-launch readiness. If you are interested, please get in touch to arrange a confidential discussion. #MedicalAffairs #InterimRole #ABPIFinalSignatory #RareDiseases #OrphanDrugs #Ophthalmology #EarlyAccess #HealthcareLeadership #MedicalStrategy #PharmaceuticalIndustry #LifeSciencesJobs #MedicalDirector #ContractRoles #BiotechJobs #LaunchExcellence #HTA #NICE #ClinicalDevelopment #PatientAccess #Compassionate Use
Contact Detail:
wax. Recruiting Team